Photobiomodulation

For those people afflicted by an ophthalmological condition called dry age-related macular degeneration (AMD), there is a new treatment that offers hope.
A Canadian clinician/researcher and his partners have developed an approach that involves periodically illuminating the patient's eye with a near-infrared light.  Results have been encouraging in arresting the condition which, when untreated, often leads to functional blindness as central vision deteriorates.
The current understanding is that the light activates the mitochondria in the retina, including the macula, and helps clear out high-molecular weight debris that has accumulated there.
Their Phase 1, NIH-approved trial took place at Toronto-area and Oak Ridge, TN clinics.  I am quite familiar with a patient who has used this treatment at home with a personally-purchased light device once a week for more than a year, and the results have been positive.
For further information on that treatment, you can consult: http://www.photospectra.ca
NIH has some facts: http://www.nei.nih.gov/health/maculardegen/armd_facts.asp
There are other treatment other than anti-oxidants usually recommended.  One is rheopheresis, a blood filtration process similar to kidney dialysis.  Unfortunately it is not available in the USA or Canada, and one must got to Austria or Germany.
There has also been an early trial of embryonic stem cell therapy that shows promise:
http://www.ncbi.nlm.nih.gov/pubmed/22281388
So, if you have dry AMD, there are legitimate treatments available, in spite of what you might be told.